FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceuticals and veterinary medicine, namely, to an agent for treating diffuse fibrocystic mastopathy in cats, including components in the following ratios, wt.%: 1% progesterone solution – 1.5; Mexidol-Vet, containing 50 mg mexidol in one tablet – 3.5; anhydrous lanolin base – 95.0.
EFFECT: hormonal local immunostimulating effect of the medicinal product in the treatment of diffuse fibrocystic mastopathy in cats, reduction of the duration of treatment.
1 cl, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MASTOPATHY | 2023 |
|
RU2819077C1 |
| MILK-WAX WALNUT AND BUCKEYE OINTMENT | 2011 |
|
RU2448683C1 |
| METHOD FOR TREATING MASTOPATHY | 2002 |
|
RU2226400C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PROLIFERATIVE MAMMARY GLAND DISEASES | 2005 |
|
RU2318508C2 |
| METHOD OF TREATING FIBROCYSTIC DISEASE IN GYNAECOLOGIC PATIENTS | 2009 |
|
RU2405598C2 |
| METHOD FOR TREATMENT OF MASTOPATHY | 2003 |
|
RU2233669C1 |
| METHOD FOR TREATING UTERINE MASTOPATHY AND MYOMA | 1998 |
|
RU2132189C1 |
| METHOD FOR BENIGN BREAST DISEASES TREATMENT | 2017 |
|
RU2641168C1 |
| "MAMOCLAM" PREPARATION FOR TREATING MASTOPATHY | 2002 |
|
RU2205019C1 |
| METHOD OF ESTIMATING EFFICIENCY OF DIFFUSE MASTOPATIA TREATMENT | 2010 |
|
RU2449724C1 |
